Key Moments
244 ‒ The history of the cell, cell therapy, gene therapy, and more | Siddhartha Mukherjee
Key Moments
Siddhartha Mukherjee discusses cells, gene therapy, and the future of medicine, highlighting historical breakthroughs and ethical considerations.
Key Insights
The cell is fundamental to life, bringing DNA's genetic code to life and enabling complex functions.
Understanding cells transformed medicine from 'witchcraft' to a scientific era, underpinning germ theory and treatments.
Multicellularity evolved independently multiple times, driven by factors like predation and resource access.
Cellular therapies offer diverse approaches, from simple drug interventions to complex gene editing like CAR T-cells.
Gene therapy's evolution, marked by early challenges like the Jesse Gelsinger case, has led to more precise tools like CRISPR.
CRISPR allows precise genetic editing, revolutionizing potential treatments for genetic diseases like sickle cell anemia.
Ethical boundaries between treating disease and pursuing enhancement are crucial in gene editing discussions.
The brain's complexity, involving electrochemical signaling and 'sand in the eye' problems, requires new paradigms in neuroscience.
Writing about science requires a synthesis of personal experience, history, and philosophy to create relatable narratives.
The decline in physical health due to falls in older adults and depression highlight the interconnectedness of cellular function and overall well-being.
THE CELL AS THE ESSENCE OF LIFE
Siddhartha Mukherjee's "The Song of the Cell" positions the cell as the fundamental unit that animates DNA's genetic code. Unlike DNA, which is a lifeless molecule, the cell acts as a 'musician,' bringing the genetic 'score' to life and enabling all biological functions. This trilogy, including "The Gene" and "The Song of the Cell," explores life from its informational basis (genes) to its operational unit (cells) and then to the consequences of cellular dysfunction, particularly in cancer.
HISTORICAL LEAPS: FROM GERM THEORY TO CELLULAR BIOLOGY
The understanding of cells fueled a critical leap in medicine, moving it from 'witchcraft' to a scientific discipline. The invention of the microscope in the 17th century allowed for the visualization of cells and, later, microbes, directly leading to germ theory. This era saw audacious statements like Rudolph Virchow's in the mid-19th century, positing that all physiological functions and all illnesses are consequences of cellular activity, a concept that advanced rapidly, unlike the slower progression in genetics during the same period.
THE EVOLUTIONARY DRIVE TOWARDS MULTICELLULARITY
The transition from single-celled organisms to multicellular life was not a singular event but evolved independently multiple times. While single-celled organisms are remarkably successful, the drive towards multicellularity is thought to be linked to advantages like increased size for defense, the capacity for specialized movement against predators, and more efficient access to food and resources, as demonstrated by experiments like Richard Ratcliffe's with yeast, which evolved into complex multicellular forms with specialized cellular suicide for reproduction.
A TYPOLOGY OF CELLULAR THERAPIES
Modern medicine utilizes cells as therapeutics in four primary ways. The first involves using drugs to alter cell behavior, such as antibiotics targeting microbial cells. The second is the direct transfer of unmodified cells, like blood transfusions. The third is using cells to synthesize therapeutic substances, such as antibodies. The fourth, and most advanced, is genetically modifying cells before therapeutic use, exemplified by CAR T-cells and gene-edited bone marrow transplants, blurring the lines between gene and cell therapy.
THE EVOLUTION OF GENE THERAPY: FROM CHALLENGES TO PRECISION
Early gene therapy efforts, like the Jesse Gelsinger case, faced significant setbacks due to immune responses against viral vectors. This led to a decade-long pause, prompting the development of safer strategies such as targeting immune-privileged sites (e.g., the retina), using less immunogenic vectors, or dampening the immune response. The advent of tools like CRISPR, discovered through studying bacterial defense mechanisms, revolutionized gene therapy, enabling precise edits within the genome rather than simply inserting new pages, as was the earlier approach.
CRISPR AND THE ETHICAL FRONTIER OF GENE EDITING
CRISPR technology allows for highly precise genetic modifications, offering new hope for treating genetic diseases like sickle cell anemia through gene correction or reactivation of fetal hemoglobin. However, its power raises profound ethical questions, as seen in the controversial case of editing human embryos for HIV resistance. This case highlights the critical distinction between treating disease and pursuing enhancement, emphasizing the need for careful ethical considerations when altering the human germline, especially for non-medically necessary interventions.
UNDERSTANDING THE BRAIN: 'SAND IN THE EYE' AND LEARNING
The brain's complexity presents unique scientific challenges, often described as 'sand in the eye' problems—where a single anomaly challenges an otherwise coherent theory. The discovery of the synapse, the gap between neurons, was such a problem, revealing that neural transmission involves a switch from electrical to chemical signals. This electrochemical signaling with 'weights' allows for modulation, learning, and complex functions like consciousness, analogous to how neural networks operate and enabling the brain to process information dynamically, like a sophisticated musical composition.
THE SCIENCE OF WRITING AND PERSONAL EXPERIENCE
Mukherjee views writing as a process of thinking and understanding, drawing from history, philosophy, mythology, and personal experience. He aims to create a new genre of medical writing that integrates scientific rigor with personal narrative, inviting readers into his world to experience the exhilaration of success and the despair of failure. This approach acknowledges that understanding complex biological and medical concepts requires not just factual knowledge but also an appreciation of the human element and emotional landscape involved.
CELLULAR BREAKDOWN AND THE CHALLENGE OF AGING
The consequences of multicellular existence are starkly illustrated by events like falls in older adults, which can lead to broken femurs and subsequent organ failure. This phenomenon underscores the interconnectedness of bodily systems, where the failure of one component, influenced by cellular processes like osteoclast and osteoblast activity, can cascade through the entire 'citizenship' of the body. This highlights the liabilities of a complex, interdependent system, where the decline of one part can compromise the whole.
DEPRESSION, DISEASE, AND THE BRAIN'S PHYSIOLOGY
Mukherjee advocates for treating mental health conditions like depression as organic disorders rooted in brain physiology, akin to diabetes or heart disease. He challenges the societal tendency to associate victimhood and blame with mental illness, arguing that the brain, like other organs, has distinct physiological circuits. By framing depression as a dysfunction of mood-regulating neurons, he aims to destigmatize it and pave the way for more effective, scientifically grounded treatments, emphasizing the need for biomarkers and a deeper understanding of neural circuit function.
Mentioned in This Episode
●Software & Apps
●Organizations
●Books
●Concepts
●People Referenced
Common Questions
Siddhartha Mukherjee's 'Life Series' aims to explain how we understand and manipulate life. It includes 'The Emperor of All Maladies', 'The Gene', and 'The Song of the Cell'. They can be read in chronological order of appearance, delving progressively deeper into the mysteries of cancer and cell biology, or in a thematic order starting with 'The Gene'.
Topics
Mentioned in this video
Siddhartha Mukherjee's first book, described as part of his 'life series' trilogy, focusing on the history of cancer and cancer therapy.
Siddhartha Mukherjee's most recent book, completing his 'life series' trilogy, which focuses on the cell as the 'musician' that brings genetic scores to life, and its role in health and disease.
Siddhartha Mukherjee's second book in the 'life series', which delves into genetics as the smallest unit of information, explaining that genes are lifeless without cells.
A young patient who died at 18 during an early gene therapy trial in 1999 at the University of Pennsylvania, due to a severe immune response to the adenovirus vector used to correct an enzyme defect in his liver.
Pioneered the invention of the single-lens microscope in the 17th century, enabling the visualization of microscopic forms and driving the early advancements in cell biology.
His evolutionary principles of natural selection were simulated in Ratcliffe's yeast experiment, described as 'Darwin in a bottle' due to the rapid evolution of multicellular forms.
Author of 'The Goon Squad', mentioned in an analogy to illustrate the lack of precision in old gene therapy methods, like inserting a random page into a specific book.
A Chinese scientist who controversially created the first genetically modified human embryos (Lulu and Nana) using CRISPR, aiming for HIV resistance, despite no medical necessity.
A prominent physician from 125 years ago, mentioned to contrast the difficulty of diagnosing heart and liver failure in his era with the ease modern medical students have today.
Mentioned as one of the scientists who picked up Gregor Mendel's work in genetics after a long period of silence.
Scientist mentioned as assisting in the development and application of CRISPR technology, contributing to the genetic revolution.
The great surgeon who began sterilizing his instruments, connecting to the idea of microbes even before they were widely seen, and contributing to the transition of medicine from 'witchcraft' to modern practice.
A junior obstetrician in Vienna who discovered that doctors were transmitting microbes, leading to high maternal mortality rates. He insisted on handwashing with bleach, drastically reducing deaths, effectively founding germ theory in the abstract.
The pseudonyms for the twin girls whose embryos were controversially genetically modified by He Jiankui using CRISPR, making them the first gene-edited human babies.
Co-discoverer of the CRISPR-Cas9 gene editing technology with Jennifer Doudna, which revolutionized the field of genetics.
A researcher known for her work on electrical stimulation therapies to treat psychiatric problems, mentioned in the context of new approaches to mental health.
A key scientist whose discoveries, along with Emmanuelle Charpentier and others, revolutionized genetics with the CRISPR system, enabling precise gene editing.
Host Peter Attia's guest, an oncologist and author of 'The Emperor of All Maladies', 'The Gene', and 'The Song of the Cell', discussing his work on the 'life series' of books.
An essayist and paleontologist known for discussing natural biophysical limitations on size, specifically the volume to surface area ratio, which can impact a creature's ability to sustain aerobic living.
Author mentioned in an analogy to explain the precision of CRISPR, contrasting it with crude gene therapy that would be like inserting an irrelevant page into his book.
A patient who was successfully treated with CAR T-cell therapy at age 7 for leukemia and is now 16 or 17, completely cured, serving as an example of the therapy's miraculous potential.
Author of a biography on Jennifer Doudna, which explores the complex relationship between science and philosophy, particularly regarding gene editing ethics.
A key figure in cellular biology who made audacious statements in the mid to late 19th century, asserting that all bodily functions and illnesses are consequences of cellular physiology and dysfunction.
Mentioned in speculation as possibly having inherited the Marfan gene due to his notable height, illustrating the effects of 'shove genes'.
A pioneer in genetics whose work experienced a long period of silence before being picked up by others, contrasting with the continuous development in cell biology.
A professor who studies the evolutionary transition from single-cell to multicellular organisms, famous for his simple experiments culturing yeast to evolve into multicellular, snowflake-like forms with specialized functions.
Scientist mentioned alongside others for his contributions to the genetic revolution and the development of CRISPR technology.
A medical school classmate of Peter Attia, described as brilliant and author of a fantastic book that addresses the complexities of mental health and the lack of biomarkers in psychiatry.
An author who has written extensively about depression and mental illness, referenced in the discussion about psychiatric diseases.
Revolutionary gene editing technology (originating from a bacterial system) that allows for extraordinarily precise changes in the human genome, such as deleting or changing a single word/letter in a massive 'library' of genes.
A type of gene therapy where a patient's T-cells are genetically modified into 'weaponized' CAR T-cells to recognize and kill cancer cells, showing significant success in blood cancers like lymphoma and leukemia.
A gene in the human genome that, when modified, can make cells resistant to HIV infection. This gene was targeted by He Jiankui in his controversial CRISPR embryo editing.
A devastating, 100% penetrant genetic disease that shortens life and causes immense suffering, discussed as a strong candidate for germline gene editing due to clear medical necessity.
A type of virus used as a vector in early gene therapy trials, including Jesse Gelsinger's case. It can cause common colds and, when used in large doses, trigger a fatal immune response.
A prestigious international graduate scholarship, which Siddhartha Mukherjee received to study at Oxford where he learned immunology.
An ancient genetic disease caused by a single amino acid mutation, leading to sickled red blood cells, clogging, and micro-strokes. Discussed as a target for multiple promising gene therapy approaches.
A genetic disorder caused by a single 'shove gene' mutation, resulting in extreme height and other complications, used to illustrate how powerful single genes can be.
Where Siddhartha Mukherjee pursued his PhD as a Rhodes Scholar, learning immunology in a lab environment.
Mentioned as a place where one receives a great medical education, but it is contrasted with the practical, hands-on learning acquired in a laboratory setting.
The institution where the ill-fated gene therapy trial for Jesse Gelsinger took place around the year 2000.
A genetic risk factor for Alzheimer's disease, mentioned as an example of a less penetrant gene compared to Huntington's, raising complex ethical questions for gene editing.
More from Peter Attia MD
View all 150 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free